LKFT at a glance
- As of June 30, 2026, 17 institutional investment managers tracked by SignalX reported holding Lakefront Biotherapeutics NV (LKFT) shares worth $580.3 million in 13F-HR filings.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Insiders · 90 days
- 0 buys · 0 sells
- No open-market trades
- 13F holders
- 17 funds
- $580.3M · +0 vs prior quarter
SignalX for LKFT
Don't miss the next LKFT filing
- Alerts as it files. A push when LKFT files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut LKFT, by share count.
- Ask anything. An AI agent that reads every LKFT filing and answers with sources.
LKFT alerts on your phone. Follow it in the SignalX Android app.
13F Fund Holdings: Quarterly Trend
Latest: Q2 2026Aggregate LKFT share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q2 2026 | 17 | $580.3M |
| Q1 2026 | 17 | $579.9M |
| Q4 2025 | 16 | $648.2M |
| Q3 2025 | 16 | $672.8M |
| Q2 2025 | 15 | $548.1M |
| Q1 2025 | 13 | $475.7M |
| Q4 2024 | 8 | $518.7M |
| Q3 2024 | 6 | $20.9M |
- Renaissance Technologies LLC+92.4K (+29%)
- Millennium Management+73.2K (+68%)
- Two Sigma Investments+55.9K (+216%)
- BlackRock+26.0K (+8%)
- Goldman Sachs Group+11.2K (+25%)
- Ameriprise Financial−152.4K (-11%)
- Citadel Advisors LLC−36.1K (-29%)
- D.E. Shaw & Co−17.9K (-8%)
- Bank of America Corp−13.2K (-64%)
- Citigroup−144 (-29%)
Source: 13F-HR filings on SEC EDGAR (aggregated from 108 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
Related Health Care companies
- AARD · Aardvark Therapeutics, Inc.Pharmaceutical Preparations
- ABT · Abbott LaboratoriesPharmaceutical Preparations
- ABBV · AbbVie IncPharmaceutical Preparations
- ABEO · ABEONA THERAPEUTICS INC.Pharmaceutical Preparations
- ACAD · ACADIA PHARMACEUTICALS INCPharmaceutical Preparations
- ACRS · Aclaris Therapeutics, Inc.Pharmaceutical Preparations
- ACTU · ACTUATE THERAPEUTICS, INC.Pharmaceutical Preparations
- ADCT · ADC Therapeutics SAPharmaceutical Preparations
LKFT SEC filings: frequently asked questions
Which institutions hold LKFT stock?
As of June 30, 2026, the largest Lakefront Biotherapeutics NV (LKFT) holders among the 13F filers tracked by SignalX were Gilead Sciences ($500.2 million), Ameriprise Financial ($38.1 million), Renaissance Technologies LLC ($12.2 million), BlackRock ($10.1 million), D.E. Shaw & Co ($5.9 million). 13F-HR reports are filed up to 45 days after each quarter ends.
What is LKFT's SEC CIK number?
Lakefront Biotherapeutics NV (LKFT)'s SEC Central Index Key (CIK) is 1421876. EDGAR lists every LKFT filing under that number.
Ask anything about LKFT
The research agent reads LKFT's filings, financials, insider trades and 13F holders, then answers with sources.